Table 3 Patient baseline characteristics per group in the study on standardized consultation for patients with osteoarthritis of the knee (second motivating example)
Characteristics | Control | Standardized consultation | p | SDiff (%) |
|---|---|---|---|---|
n 0 =146 | n 1=181 | |||
mean (standard deviation) | mean (standard deviation) | |||
Age (years) | 64.5 (8.4) | 63.9 (8.1) | 0.4720 | 8.02 |
Weight (kg) | 81.4 (13.6) | 84.1 (12.9) | 0.0665 | 20.60 |
BMI (kg.m −2) | 30.2 (3.8) | 31.2 (3.5) | 0.0143 | 27.63 |
PEL (0-5) | 2.2 (0.9) | 2.2 (0.8) | 0.9594 | 0.00 |
Delay since beginning of pain (years) | 5.5 (5.9) | 7.4 (7.5) | 0.0152 | 27.57 |
Age at beginning of pain (years) | 59.1 (10.4) | 56.5 (10.5) | 0.0300 | 24.28 |
Pain (0-10) | 5.6 (1.3) | 5.5 (1.2) | 0.3646 | 10.38 |
WOMAC function score (0-100) | 29.9 (12.2) | 30.3 (11.7) | 0.7377 | 3.76 |
SF-12 physical subscale | 34.8 (6.7) | 35.4 (6.7) | 0.4385 | 8.70 |
SF-12 mental subscale | 41.4 (9.4) | 43.3 (10.1) | 0.0827 | 19.31 |
Global assessment of disease status (0-10) | 5.6 (1.5) | 5.6 (1.5) | 0.9133 | 1.31 |
n (%) | n (%) | |||
Male | 49 (27.1) | 34 (23.3) | 0.5132 | 8.73 |
Prior treatments | ||||
Analgesics | 130 (71.8) | 96 (65.8) | 0.2889 | 13.13 |
NSAIDs | 95 (52.5) | 90 (61.6) | 0.1215 | 18.58 |
Current use of NSAIDS | 160 (88.4) | 126 (86.3) | 0.6883 | 6.31 |
SYSADOA | 74 (40.9) | 68 (46.6) | 0.3576 | 11.49 |
Current use of SYSADOA | 179 (98.9) | 145 (99.3) | 1.0000 | 4.46 |
IA treatment | 31 (17.1) | 29 (19.9) | 0.6229 | 7.05 |
Non-drug treatment | 110 (60.8) | 71 (48.6) | 0.0372 | 24.58 |
Diet | 49 (27.1) | 31 (21.2) | 0.2750 | 13.67 |
Dietetician | 12 (6.6) | 7 (4.8) | 0.6401 | 7.91 |
Physical exercice | 44 (24.3) | 27 (18.5) | 0.2571 | 14.22 |
Physiotherapy | 30 (16.6) | 17 (11.6) | 0.2692 | 14.20 |
Knee orthosis | 21 (11.6) | 11 (7.5) | 0.2967 | 13.86 |
Insoles | 24 (13.3) | 11 (7.5) | 0.1376 | 18.84 |
Walking sticks | 13 (7.2) | 10 (6.8) | 1.0000 | 1.30 |